BEGIN:VCALENDAR
VERSION:2.0
PRODID:spatie/icalendar-generator
DESCRIPTION:Events from OAG
X-WR-CALDESC:Events from OAG
REFRESH-INTERVAL;VALUE=DURATION:PT1440M
X-PUBLISHED-TTL:PT1440M
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:STANDARD
DTSTART:20191027T030000Z
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20200329T020000Z
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART:20250802T071239Z
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:138-58
DTSTAMP:20260429T071239Z
SUMMARY:The Corona Virus - First Successes in Drug Development?  
LOCATION:
ORGANIZER;CN=stellae_superadmin:MAILTO:niko@stellae.studio
DTSTART;TZID=Europe/Vienna:20200309T183000
DTEND;TZID=Europe/Vienna:20200309T235900
X-ALT-DESC;FMTTYPE=TEXT/HTML:The Corona Virus - First Successes in Drug Dev
 elopment? rn For the current occasion\, the Austrian-American Society invi
 ted to a top-class expert lecture. Moderated by Johannes Dobretsberger (Or
 acle Austria GmbH)\, the globally sought-after molecular biologist Prof. D
 r. Josef Penninger held a lecture on the status quo and gave an outlook. 
 ÖAG President Philipp Bodzenta and&hellip\;
CATEGORIES:EN
URL;VALUE=URI:https://www.oag.at/mc-events/the-corona-virus-first-successes
 -in-drug-development/?mc_id=138
END:VEVENT
END:VCALENDAR